Sodium butyrate activates erythroid-specific 5-aminolevulinate synthase gene through Sp1 elements at its promoter

Blood Cells, Molecules, and Diseases

Volumn 41, Issue 2, 2008, Pages 148-153

  Han, Liping ^a,b,c   Zhong, Yun ^a,c   Huang, Binlu ^a,c   Han, Limei ^a,c   Pan, Lina ^a,c   Xu, Xin ^a,c   Wang, Xiuli ^a,c   Huang, Baiqu ^a,c   Lu, Jun ^a,c  

^a NORTHEAST NORMAL UNIVERSITY   (China)

^b CHANGCHUN NORMAL UNIVERSITY   (China)

^c SHENYANG AGRICULTURAL UNIVERSITY   (China)

Author keywords

ALAS2; HDAC1; Histone acetylation; Sodium butyrate; Sp1; Transcription regulation

Indexed keywords

5 AMINOLEVULINATE SYNTHASE; BUTYRIC ACID; HISTONE DEACETYLASE 1; HISTONE H3; LYSINE; TRANSCRIPTION FACTOR SP1;

ACETYLATION; ARTICLE; BINDING SITE; CELL LINEAGE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EMBRYO; ERYTHROID CELL; GENE ACTIVATION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; METHYLATION; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; REPORTER GENE; SITE DIRECTED MUTAGENESIS; UPREGULATION;

5-AMINOLEVULINATE SYNTHETASE; ACETYLATION; BUTYRATES; CELL LINE, TUMOR; ENHANCER ELEMENTS (GENETICS); ERYTHROID CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HISTONE DEACETYLASES; HISTONES; HUMANS; METHYLATION; MUTAGENESIS, SITE-DIRECTED; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; SP1 TRANSCRIPTION FACTOR; UP-REGULATION;

EID: 48749127300     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2008.04.002     Document Type: Article

References (22)

1. Bishop D.F., Henderson A.S., and Astrin K.H. Human delta-aminolevulinate synthase: assignment of the housekeeping gene to 3p21 and the erythroid-specific gene to the X chromosome. Genomics 7 (1990) 207-214
2. Meguro K., Igarashi K., Yamamoto M., et al. The role of the erythroid-specific delta-aminolevulinate synthase gene expression in erythroid heme synthesis. Blood 86 (1995) 940-948
3. Sadlon T.J., Dell'Oso T., Surinya K.H., and May B.K. Regulation of erythroid 5-aminolevulinate synthase expression during erythropoiesis. Int. J. Biochem. Cell Biol. 31 (1999) 1153-1167
4. Fujiwara T., Harigae H., Takahashi S., et al. Differential gene expression profiling between wild-type and ALAS2-null erythroblasts: identification of novel heme-regulated genes. Biochem. Biophys. Res. Commun. 340 (2006) 105-110
5. Nakajima O., Takahashi S., Harigae H., et al. Heme deficiency in erythroid lineage causes differentiation arrest and cytoplasmic iron overload. EMBO J. 18 (1999) 6282-6289
6. Davie J.R. Inhibition of histone deacetylase activity by butyrate. J. Nutr. 133 (2003) 2485S-2493S
7. Garcia-Manero G., and Issa J.P. Histone deacetylase inhibitors: a review of their clinical status as antineoplastic agents. Cancer Invest. 23 (2005) 635-642
8. Leder A., and Leder P. Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells. Cell 5 (1975) 319-322.
9. Wang X., Pan L., Feng Y., et al. p300 plays a role in p16INK4a expression and cell cycle arrest. Oncogene 27 (2008) 1894-1904
10. Han L., Lu J., Pan L., et al. Histone acetyltransferase p300 regulates the transcription of human erythroid-specific 5-aminolevulinate synthase gene. Biochem. Biophys. Res. Commun. 348 (2006) 799-806
11. Yang J., Kawai Y., Hanson R.W., and Arinze I.J. Sodium butyrate induces transcription from the G alpha(i2) gene promoter through multiple Sp1 sites in the promoter and by activating the MEK-ERK signal transduction pathway. J. Biol. Chem. 276 (2001) 25742-25752
12. Siavoshian S., Segain J.P., Kornprobst M., et al. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. Gut 46 (2000) 507-514
13. Lu Y., and Lotan R. Transcriptional regulation by butyrate of mouse galectin-1 gene in embryonal carcinoma cells. Biochim. Biophys. Acta 1444 (1999) 85-91
14. Walker G.E., Wilson E.M., Powell D., and Oh Y. Butyrate, a histone deacetylase inhibitor, activates the human IGF binding protein-3 promoter in breast cancer cells: molecular mechanism involves an Sp1/Sp3 multiprotein complex. Endocrinology 142 (2001) 3817-3827
15. Surinya K.H., Cox T.C., and May B.K. Transcriptional regulation of the human erythroid 5-aminolevulinate synthase gene. J. Biol. Chem. 272 (1997) 26585-26594
16. Doetzlhofer A., Rotheneder H., Lagger G., et al. Histone deacetylase 1 can repress transcription by binding to Sp1. Mol. Cell Biol. 19 (1999) 5504-5511
17. Cucciolla V., Borriello A., Criscuolo M., et al. Histone deacetylase inhibitors up-regulate p57Kip2 level by enhancing its expression through Sp1 transcription factor. Carcinogenesis 29 (2008) 560-567
18. Duan H., Heckman C.A., and Boxer L.M. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas. Mol. Cell Biol. 25 (2005) 1608-1619
19. Kiela P.R., Kuscuoglu N., Midura A.J., et al. Molecular mechanism of rat NHE3 gene promoter regulation by sodium butyrate. Am. J. Physiol. Cell Physiol. 293 (2007) C64-C74
20. Kaczynski J., Cook T., and Urrutia R. Sp1- and Krüppel-like transcription factors. Genome Biol. 4 (2003) 206
21. Schneider R., Bannister A.J., Myers F.A., et al. Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat. Cell Biol. 6 (2004) 73-77
22. Kim A., and Dean A. Developmental stage differences in chromatin subdomains of the β-globin locus. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 7028-7033